267 related articles for article (PubMed ID: 18562529)
21. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
Zhou X; Evans SL; Han X; Liu Y; Yu XF
PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
[TBL] [Abstract][Full Text] [Related]
22. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
23. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
24. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.
Zhang J; Wu J; Wang W; Wu H; Yu B; Wang J; Lv M; Wang X; Zhang H; Kong W; Yu X
Retrovirology; 2014 Sep; 11():77. PubMed ID: 25213124
[TBL] [Abstract][Full Text] [Related]
25. Jembrana disease virus Vif antagonizes the inhibition of bovine APOBEC3 proteins through ubiquitin-mediate protein degradation.
Su X; Wang H; Zhou X; Li Z; Zheng B; Zhang W
Virology; 2018 Jun; 519():53-63. PubMed ID: 29653302
[TBL] [Abstract][Full Text] [Related]
26. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
[TBL] [Abstract][Full Text] [Related]
27. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
[TBL] [Abstract][Full Text] [Related]
28. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
Kohroki J; Nishiyama T; Nakamura T; Masuho Y
FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
[TBL] [Abstract][Full Text] [Related]
29. Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.
Wang H; Lv G; Zhou X; Li Z; Liu X; Yu XF; Zhang W
BMC Microbiol; 2014 Nov; 14():290. PubMed ID: 25424878
[TBL] [Abstract][Full Text] [Related]
30. Molecular structure and biochemical properties of the HCCH-Zn2+ site in HIV-1 Vif.
Giri K; Scott RA; Maynard EL
Biochemistry; 2009 Aug; 48(33):7969-78. PubMed ID: 19588889
[TBL] [Abstract][Full Text] [Related]
31. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
[TBL] [Abstract][Full Text] [Related]
32. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.
Zhen A; Wang T; Zhao K; Xiong Y; Yu XF
J Virol; 2010 Feb; 84(4):1902-11. PubMed ID: 19939923
[TBL] [Abstract][Full Text] [Related]
33. Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.
Wang X; Wang X; Wang W; Zhang J; Wang J; Wang C; Lv M; Zuo T; Liu D; Zhang H; Wu J; Yu B; Kong W; Wu H; Yu X
Biochem Biophys Res Commun; 2015 Jun; 461(4):624-9. PubMed ID: 25912140
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation.
Lv W; Liu Z; Jin H; Yu X; Zhang L; Zhang L
Org Biomol Chem; 2007 Feb; 5(4):617-26. PubMed ID: 17285170
[TBL] [Abstract][Full Text] [Related]
35. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for HIV-1 antagonism of host APOBEC3G via Cullin E3 ligase.
Ito F; Alvarez-Cabrera AL; Liu S; Yang H; Shiriaeva A; Zhou ZH; Chen XS
Sci Adv; 2023 Jan; 9(1):eade3168. PubMed ID: 36598981
[TBL] [Abstract][Full Text] [Related]
38. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D
J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Huang W; Zuo T; Jin H; Liu Z; Yang Z; Yu X; Zhang L; Zhang L
Mol Divers; 2013 May; 17(2):221-43. PubMed ID: 23378232
[TBL] [Abstract][Full Text] [Related]
40. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]